Fundz

Dyne Therapeutics, Inc. reported raising $116 Million in an initial SEC Form D filing, from an offering of $116 Million

PUBLIC · DYNAug 14, 2020

Amount Raised

$116 Million

$116 Million sold, per SEC Form D (first sale Aug 14, 2020)

Round Type

Venture

WalthamBiotechnologyHealth CareTherapeutics

Quick answer

Dyne Therapeutics raised $116 Million in a funding round, dated August 14, 2020. Dyne Therapeutics is based in Waltham, Massachusetts, United States.

How much did Dyne Therapeutics raise?
Dyne Therapeutics raised $116 Million in a funding round on August 14, 2020.
What does Dyne Therapeutics do?
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.
Where is Dyne Therapeutics based and how big is it?
Dyne Therapeutics is based in Waltham, Massachusetts, United States. Fundz records about 270 employees.
Who are the decision-makers at Dyne Therapeutics?
Fundz holds 2 contacts at Dyne Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Dyne Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Oragenics raised an undisclosed amount (Funding Round) on September 28, 2020.
  • Azora Therapeutics, Inc. (DE) raised $500K on September 25, 2020.
  • Asceneuron raised $85M (Series C) on September 23, 2020.
  • Libra Therapeutics raised $29M (Series A) on September 23, 2020.
  • LAVA Therapeutics raised $83M (Series C) on September 17, 2020.
  • BioNTech raised $250M on September 17, 2020.

Who to call at Dyne Therapeutics, and when

A new round usually means Dyne Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Dyne Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Dyne Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Dyne Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Dyne Therapeutics

Location

1560 Trapelo Road

Waltham, Massachusetts, United States

About

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Dyne Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts11 people are listed at Dyne Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Dyne Therapeutics's next move

See what Strategic adds

Dyne Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.